Altimmune, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $43.8M | $36.9M | $135.1M | $111.1M | $190.3M | $115.9M | $9.0M | $33.7M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $278.2M | $137.3M | $209.6M | $192.8M | $204.1M | $230.3M | $39.4M | $39.4M |
| Property, Plant & Equipment | $312.0K | $413.0K | $651.0K | $1.1M | $1.4M | $1.1M | $1.1M | $1.3M |
| Goodwill | — | — | — | — | — | — | $0 | $0 |
| Intangible Assets (Excl. Goodwill) | — | $0 | $0 | $12.4M | $12.4M | $12.8M | $12.7M | $13.9M |
| Total Assets | $279.9M | $139.3M | $210.6M | $206.9M | $218.9M | $245.1M | $54.1M | $54.8M |
| Liabilities | ||||||||
| Accounts Payable | $2.7M | $211.0K | $2.1M | $4.8M | $2.0M | $612.3K | $18.2K | $372.9K |
| Total Current Liabilities | $15.0M | $10.5M | $12.1M | $17.1M | $18.3M | $12.0M | $3.9M | $4.5M |
| Long-Term Debt | $34.3M | — | — | $4.6M | $1.5M | $1.8M | $1.9M | $1.9M |
| Total Liabilities | $55.0M | $15.8M | $16.5M | $21.6M | $19.7M | $19.2M | $8.5M | $6.4M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-649.5M | $-561.4M | $-466.3M | $-377.9M | $-293.2M | $-186.4M | $-137.4M | $-116.9M |
| Total Stockholders' Equity | $224.9M | $123.5M | $194.1M | $185.3M | $199.1M | $225.9M | $45.5M | $48.3M |